Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03420950 · ClinicalTrials.gov registry record · NA
Drug Order for Rapid Sequence Intubation
A NA study, sponsored by Hennepin Healthcare Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 335
- Enrollment target
NCT03420950 is a NA study that has completed, run by Hennepin Healthcare Research Institute. The registered enrollment target is 335 participants.
The verdict
NCT03420950, a NA study, has completed, sponsored by Hennepin Healthcare Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 335 participants
- Enrollment target
Study Summary
This is a randomized, blinded trial comparing the order of drug administration for rapid sequence intubation in the Emergency Department.
Interventions
- OTHER Rapid sequence intubation: sedative first
- OTHER Rapid sequence intubation: paralytic first
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2018-02-05 |
| Est. Completion | 2021-09-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03420950
The ClinicalTrials.gov registry entry for NCT03420950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hennepin Healthcare Research Institute, which has 63 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rapid sequence intubation: sedative first is the first listed.
NCT03420950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03420950 about?
NCT03420950 is a clinical study titled "Drug Order for Rapid Sequence Intubation". This is a randomized, blinded trial comparing the order of drug administration for rapid sequence intubation in the Emergency Department.
What is the current status of trial NCT03420950?
This trial is currently completed. It is a NA study. The enrollment target is 335 participants. The study started on 2018-02-05. Estimated completion is 2021-09-29.
What interventions are being tested in trial NCT03420950?
The interventions under investigation include: Rapid sequence intubation: sedative first (OTHER), Rapid sequence intubation: paralytic first (OTHER).
Who is sponsoring clinical trial NCT03420950?
This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.